These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 2353459)
41. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Shukla A; Katare OP; Singh B; Vyas SP Int J Pharm; 2010 Jan; 385(1-2):47-52. PubMed ID: 19835938 [TBL] [Abstract][Full Text] [Related]
42. A frameshift mutation in the pre-S region of the human hepatitis B virus genome allows production of surface antigen particles but eliminates binding to polymerized albumin. Persing DH; Varmus HE; Ganem D Proc Natl Acad Sci U S A; 1985 May; 82(10):3440-4. PubMed ID: 3858831 [TBL] [Abstract][Full Text] [Related]
43. Interactions between hepatitis B virus and polymeric human albumin. I. Production of monoclonal anti-idiotypes (anti-anti-polymeric human albumin) which recognize hepatitis B virus surface antigen. Colucci G; Waksal SD Eur J Immunol; 1987 Mar; 17(3):365-70. PubMed ID: 3032648 [TBL] [Abstract][Full Text] [Related]
44. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity. Wu L; He JW; Yao X; Li HM; Wen YM J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722 [TBL] [Abstract][Full Text] [Related]
45. An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells. Wen WH; Qin WJ; Gao H; Zhao J; Jia LT; Liao QH; Meng YL; Jin BQ; Yao LB; Chen SY; Yang AG J Viral Hepat; 2007 Jul; 14(7):512-9. PubMed ID: 17576393 [TBL] [Abstract][Full Text] [Related]
46. Recombinant hepatitis B virus surface antigen formulated with B-type CpG oligodeoxynucleotide induces therapeutic immunity against hepatitis B virus surface antigen-expressing liver cancer cells in mice. Zhou X; Wei H; Sun P; Wu X; Wan M; Zhang P; Guo S; Zhao T; Yu Y; Wang L Cancer Biother Radiopharm; 2012 May; 27(4):234-42. PubMed ID: 22537404 [TBL] [Abstract][Full Text] [Related]
47. A human-derived protein SBP (HBsAg-binding protein) can bind to hepatitis B virus surface antigen (HBsAg) and enhance the immune response to hepatitis B virus (HBV) vaccine. Zhang C; Gong L; Chen Y; Wang X; Zhu S; Li D; Pang Y; Yin Y; Liu X; Zhu N Mol Immunol; 2013 Jan; 53(1-2):60-71. PubMed ID: 22809814 [TBL] [Abstract][Full Text] [Related]
48. A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge. del Valle JR; Devaux P; Hodge G; Wegner NJ; McChesney MB; Cattaneo R J Virol; 2007 Oct; 81(19):10597-605. PubMed ID: 17634218 [TBL] [Abstract][Full Text] [Related]
49. Extraction and purification of hepatitis B virus-like M particles from a recombinant Saccharomyces cerevisiae strain using alumina powder. Hadiji-Abbes N; Martin M; Benzina W; Karray-Hakim H; Gergely C; Gargouri A; Mokdad-Gargouri R J Virol Methods; 2013 Jan; 187(1):132-7. PubMed ID: 23059550 [TBL] [Abstract][Full Text] [Related]
50. Aggregation and antigenicity of virus like particle in salt solution--A case study with hepatitis B surface antigen. Chen Y; Zhang Y; Quan C; Luo J; Yang Y; Yu M; Kong Y; Ma G; Su Z Vaccine; 2015 Aug; 33(35):4300-6. PubMed ID: 25862298 [TBL] [Abstract][Full Text] [Related]
51. Immunological properties of recombinant HBsAg produced in yeast. Hauser P; Voet P; Simoen E; Thomas HC; PĂȘtre J; De Wilde M; Stephenne J Postgrad Med J; 1987; 63 Suppl 2():83-91. PubMed ID: 2446304 [TBL] [Abstract][Full Text] [Related]
52. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen. Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583 [TBL] [Abstract][Full Text] [Related]
53. Characterization of pre-s gene products in hepatitis B surface antigen. Stibbe W; Gerlich WH Dev Biol Stand; 1983; 54():33-43. PubMed ID: 6653888 [TBL] [Abstract][Full Text] [Related]
54. Update on diagnosis, management, and prevention of hepatitis B virus infection. Mahoney FJ Clin Microbiol Rev; 1999 Apr; 12(2):351-66. PubMed ID: 10194463 [TBL] [Abstract][Full Text] [Related]
55. Hepatitis B virus surface antigen binds to apolipoprotein H. Mehdi H; Kaplan MJ; Anlar FY; Yang X; Bayer R; Sutherland K; Peeples ME J Virol; 1994 Apr; 68(4):2415-24. PubMed ID: 8139027 [TBL] [Abstract][Full Text] [Related]
56. Physiology and function of the vero cell receptor for the hepatitis B virus small S protein. Komai K; Peeples ME Virology; 1990 Jul; 177(1):332-8. PubMed ID: 2353459 [TBL] [Abstract][Full Text] [Related]
57. The Vero cell receptor for the hepatitis B virus small S protein is a sialoglycoprotein. Komai K; Kaplan M; Peeples ME Virology; 1988 Apr; 163(2):629-34. PubMed ID: 3281375 [TBL] [Abstract][Full Text] [Related]
58. A cultured cell receptor for the small S protein of hepatitis B virus. Peeples ME; Komai K; Radek R; Bankowski MJ Virology; 1987 Sep; 160(1):135-42. PubMed ID: 3629972 [TBL] [Abstract][Full Text] [Related]
59. An altered form of apolipoprotein H binds hepatitis B virus surface antigen most efficiently. Mehdi H; Yang X; Peeples ME Virology; 1996 Mar; 217(1):58-66. PubMed ID: 8599236 [TBL] [Abstract][Full Text] [Related]